Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-81.26	44.66	238.30
Graham Fair Price	659.98	3.49	0.46
PEG	-99.98	< 0.005	10.59
Price/Book	-18.47	0.81	1.00
Price/Cash Flow	94.78	-108.98	-2086.11
Prices/Earnings	-98.55	14.53	-1000.73
Price/Sales	-8.09	5.47	5.95
Price/FCF	94.78	-108.98	-2086.11
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	18.18	0.20	0.17
Operating Margin	256.71	0.10	0.03
ROA	5388.54	0.01	< 0.005
ROE	< 0.005	0.01	5516.32
ROIC	< 0.005	0.01	3302.87
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.08	0.05	49.49
Dividends QOQ	0.10	-0.96	881.16
EBIT QOQ	2.45	2.21	-9.76
EPS QOQ	0.94	59.07	6152.76
FCF QOQ	-1.02	-14.83	-1349.77
Revenue QOQ	-0.33	-0.10	69.86
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	117.86	141.20	19.80
Days Sales Outstanding (DSO)	30.67	35.40	15.39
Inventory Turnover	0.76	0.64	-16.53
Debt/Capitalization	0.02	0.02	6.34
Quick Ratio	1.18	1.15	-2.31
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	6.15	6.23	1.41
Cash	0.85	1.03	22.25
Capex	-0.02	-0.09	-301.96
Free Cash Flow	< 0.005	-0.05	-1482.73
Revenue	1.03	0.93	-10.04
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.44	2.48	1.75
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-3.03	-4.15	-37.33
Naive Interpretation	Member

06 - Financial Health · Bad

Rating